Journal of Cancer Research and Therapeutics Close
 

Figure 2: (a) Histopathological section showing low-grade urothelial carcinoma (H and E, ×20). (b) Section showing positive CD10 Score 1 in low-grade urothelial carcinoma (×20). (c) Section showing high-grade urothelial carcinoma (H and E, ×40). (d) Section showing positive CD10 Score 2 in high-grade urothelial carcinoma (×40). (e) Section showing high-grade urothelial carcinoma with deep muscle invasion (H and E, ×20). (f) Section showing positive CD10 Score 2 in high-grade urothelial carcinoma with deep muscle invasion (×20)

Figure 2: (a) Histopathological section showing low-grade urothelial carcinoma (H and E, ×20). (b) Section showing positive CD10 Score 1 in low-grade urothelial carcinoma (×20). (c) Section showing high-grade urothelial carcinoma (H and E, ×40). (d) Section showing positive CD10 Score 2 in high-grade urothelial carcinoma (×40). (e) Section showing high-grade urothelial carcinoma with deep muscle invasion (H and E, ×20). (f) Section showing positive CD10 Score 2 in high-grade urothelial carcinoma with deep muscle invasion (×20)